Robin Jones to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Robin Jones has written about Antineoplastic Agents, Immunological.
Connection Strength
0.708
-
Olaratumab for the treatment of soft-tissue sarcoma. Future Oncol. 2017 Oct; 13(24):2151-2157.
Score: 0.561
-
The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncol. 2018 May; 14(12):1197-1211.
Score: 0.148